Drug manufacturer Dr Reddys Laboratories has said that it has received US regulatory approval for antiheartburn capsules. The company has received US Food and Drug Administration approval for its Abbreviated New Drug Application for Omeprazole Mg OTC, Dr Reddys Laboratories said in a filing to BSE. Omeprazole Mg OTC is indicated for the treatment of heartburn. Dr Reddys formulation contains 20.6 mg Omeprazole Mg and the dosage form is a capsule, the filing added.
Recently an application was filed under section 97 of the Central Goods and Services Tax Act, and the Maharashtra Goods and Services Tax Act, 2017 by lNA Bearing India Private Limited, being the More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More